Log in to save to my catalogue

Endothelin-receptor antagonists in arterial hypertension: further indications?

Endothelin-receptor antagonists in arterial hypertension: further indications?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70279584

Endothelin-receptor antagonists in arterial hypertension: further indications?

About this item

Full title

Endothelin-receptor antagonists in arterial hypertension: further indications?

Publisher

United States: Springer Nature B.V

Journal title

Current hypertension reports, 2007-03, Vol.9 (1), p.59-65, Article 59

Language

English

Formats

Publication information

Publisher

United States: Springer Nature B.V

More information

Scope and Contents

Contents

Endothelin-1 exerts vasoactive, pro-inflammatory, hypertrophic, and profibrotic properties on the heart, kidney, and blood vessels. Hence, endothelin-receptor antagonists hold the potential to reduce blood pressure and to prevent complications of hypertension, atherosclerosis, and diabetes through blood pressure-independent effects on cardiovascula...

Alternative Titles

Full title

Endothelin-receptor antagonists in arterial hypertension: further indications?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_70279584

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70279584

Other Identifiers

ISSN

1522-6417

E-ISSN

1534-3111

DOI

10.1007/s11906-007-0011-9

How to access this item